cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2001; 38:1895-1901
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzone, A.
Right arrow Articles by Falcone, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzone, A.
Right arrow Articles by Falcone, C.

CLINICAL STUDY: MYOCARDIAL ISCHEMIA

Increased production of inflammatory cytokines in patients with silent myocardial ischemia

Antonino Mazzone, MD*,*, Chiara Cusa, MD*, Iolanda Mazzucchelli, BSc*, Monia Vezzoli, MD*, Elena Ottini, MD*, Roberta Pacifici, BSc{dagger}, Piergiorgio Zuccaro, MD{dagger} and Colomba Falcone, MD{ddagger}

* Department of Internal Medicine, Legnano Hospital, Milan Italy
{dagger} Clinical Biochemistry Department, National Institute of Health, Rome Italy
{ddagger} Department of Cardiology, IRCCS S. Matteo Hospital, Pavia, Italy

Manuscript received March 20, 2001; revised manuscript received August 7, 2001, accepted August 27, 2001.

* Reprint requests and correspondence: Dr. Antonino Mazzone, Chief of Internal Medicine and Oncology, Hospital of Legnano, Via Candiani 2, 20025 Legnano, Milano, Italy
medicina2legnano{at}ao-legna.no

OBJECTIVES

The aim of the study was to examine the inflammatory cytokines in patients with myocardial ischemia to evaluate whether silent ischemia patients exibit any particular cytokine pattern.

BACKGROUND

Silent myocardial ischemia is frequently observed in patients with coronary artery disease. Various endogenous mechanisms control a patient’s perceived intensity of pain. Among them, the inflammatory process and the related cytokine production are known to modulate the threshold for activating the primary afferent nociceptors.

METHODS

Seventy-eight patients with reproducible exercise-induced myocardial ischemia were studied: 34 symptomatic patients, with rest and/or stress angina; 44 asymptomatic patients, with no symptoms during daily life activities or during positive exercise stress test. Venous blood samples were taken from all patients to evaluate the expression of CD11b receptors both on neutrophils and monocytes. Frozen plasma samples (at –80°C) were used to quantify the anti-inflammatory (interleukin-4 and -10, transforming growth factor-ß) and the proinflammatory cytokines (tumor necrosis factor-{alpha}, interferon-{gamma}, interleukin-1ß and -6).

RESULTS

In asymptomatic patients lower CD11b receptor expression and higher concentration of anti-inflammatory cytokines were observed. Proinflammatory cytokine production was similar in the two groups.

CONCLUSIONS

The data suggest that an "anti-inflammatory pattern" of cytokine production correlates with silent ischemia and that the immune and inflammatory system activation may be crucial for angina symptoms.

Abbreviations and Acronyms
  CAD = coronary artery disease
  CGRP = calcitonin gene-related peptide
  ECG = electrocardiogram or electrocardiographic
  IFN-{gamma} = interferon-gamma
  IL = interleukin
  MAb = monoclonal antibodies
  MESF = molecules of equivalent soluble fluorescein
  MI = myocardial infarction
  NF-{kappa}B = nuclear factor-{kappa}B
  PBR = peripheral benzodiazepine receptor
  SP = substance P
  TGF-ß = transforming growth factor-beta
  TNF-{alpha} = tumor necrosis factor-alpha




This article has been cited by other articles:


Home page
HeartHome page
E Biagini, A F L Schinkel, J J Bax, V Rizzello, R T van Domburg, B J Krenning, M Bountioukos, C Pedone, E C Vourvouri, C Rapezzi, et al.
Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography
Heart, June 1, 2005; 91(6): 737 - 742.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Sliwa, A. Woodiwiss, V. N. Kone, G. Candy, D. Badenhorst, G. Norton, C. Zambakides, F. Peters, and R. Essop
Therapy of Ischemic Cardiomyopathy With the Immunomodulating Agent Pentoxifylline: Results of a Randomized Study
Circulation, February 17, 2004; 109(6): 750 - 755.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. F. Cohn, K. M. Fox, and C. Daly
Silent Myocardial Ischemia
Circulation, September 9, 2003; 108(10): 1263 - 1277.
[Full Text] [PDF]


Home page
Diabetes CareHome page
C. Piot, A. Fontbonne, A. Sultan, M. Rasamisoa, D. Mariano-Goulart, J.-M. Davy, L. Monnier, and A. Avignon
Inflammatory Parameters Are Independent Predictors of Severe Epicardial Coronary Stenosis in Asymptomatic Diabetic Patients With Silent Myocardial Ischemia
Diabetes Care, February 1, 2003; 26(2): 545 - 546.
[Full Text] [PDF]


Home page
CirculationHome page
S. Stern
Angina Pectoris Without Chest Pain: Clinical Implications of Silent Ischemia
Circulation, October 8, 2002; 106(15): 1906 - 1908.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home